XMD15-44
XMD15-44 is a RET kinase inhibitor.XMD15-44 has a growth-inhibitory effect on RET/C634R and RET/M918T transformed RAT1 cells, with IC50 values of 11.5 nM and 8.3 nM, respectively. XMD15-44 can inhibit RET kinase and signaling in human thyroid cancer cell lines carrying oncogenic RET alleles, reducing cell proliferation[1].
Product Specifications
CAS Number
1240489-67-1
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xmd15-44.html
Smiles
CC1=CC=C(C(NC2=CC=C(CN3CCN(CC)CC3)C(C(F)(F)F)=C2)=O)C=C1C#CC4=CN=CC=C4
Molecular Formula
C29H29F3N4O
Molecular Weight
506.56
References & Citations
[1]Moccia M, et al. Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase. PLoS One. 2015 Jun 5;10 (6) :e0128364.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Tumor necrosis factor receptor superfamily member 1B, TNFRSF1B ELISA KIT
Human Tumor necrosis factor receptor superfamily member 1B, TNFRSF1B ELISA KIT
Human Tumor necrosis factor receptor superfamily member 1B, TNFRSF1B ELISA KIT
Human Tumor necrosis factor receptor superfamily member 1B, TNFRSF1B ELISA KIT
